Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ze'ev Ronai

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
Cell Cycle (Georgetown, Tex.)|August 5, 2008
ATF2: a transcription factor that elicits oncogenic or tumor suppressor activitiesAnindita Bhoumik, Ze'ev Ronai
Cell|November 18, 2006
A new function for p53 ubiquitinationYuko Hirano, Ze'ev Ronai
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 16, 2001
GST function in drug and stress responseKenneth D. Tew, Ze'ev Ronai
Trends in Biochemical Sciences|May 2, 2006
Ubiquitin and SUMO systems in the regulation of mitotic checkpointsGustavo J Gutierrez, Ze'ev Ronai
Cancer Biology & Therapy|November 15, 2002
SUMO in cancer--wrestlers wantedDania Alarcon-Vargas, Ze'ev Ronai
The International Journal of Biochemistry & Cell Biology|January 10, 2008
Requirements for PKC-augmented JNK activation by MKK4/7Pablo Lopez-Bergami, Ze'ev Ronai
The Journal of Biological Chemistry|November 20, 2003
c-Jun-NH2 kinase (JNK) contributes to the regulation of c-Myc protein stabilityDania Alarcon-Vargas, Ze'ev Ronai
Carcinogenesis|April 19, 2002
p53-Mdm2--the affair that never endsDania Alarcon-Vargas, Ze'ev Ronai
Proceedings of the National Academy of Sciences of the United States of America|March 11, 2004
Transcriptional switch by activating transcription factor 2-derived peptide sensitizes melanoma cells to apoptosis and inhibits their tumorigenicityAnindita Bhoumik, Nic Jones, Ze'ev Ronai
Cancer Research|November 19, 2004
Inhibition of melanoma growth and metastasis by ATF2-derived peptidesAnindita Bhoumik, Lisa Gangi, Ze'ev Ronai
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
Cell Cycle (Georgetown, Tex.)|August 5, 2008
ATF2: a transcription factor that elicits oncogenic or tumor suppressor activitiesAnindita Bhoumik, Ze'ev Ronai
Cell|November 18, 2006
A new function for p53 ubiquitinationYuko Hirano, Ze'ev Ronai
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 16, 2001
GST function in drug and stress responseKenneth D. Tew, Ze'ev Ronai
Trends in Biochemical Sciences|May 2, 2006
Ubiquitin and SUMO systems in the regulation of mitotic checkpointsGustavo J Gutierrez, Ze'ev Ronai
Cancer Biology & Therapy|November 15, 2002
SUMO in cancer--wrestlers wantedDania Alarcon-Vargas, Ze'ev Ronai
The International Journal of Biochemistry & Cell Biology|January 10, 2008
Requirements for PKC-augmented JNK activation by MKK4/7Pablo Lopez-Bergami, Ze'ev Ronai
The Journal of Biological Chemistry|November 20, 2003
c-Jun-NH2 kinase (JNK) contributes to the regulation of c-Myc protein stabilityDania Alarcon-Vargas, Ze'ev Ronai
Carcinogenesis|April 19, 2002
p53-Mdm2--the affair that never endsDania Alarcon-Vargas, Ze'ev Ronai
Proceedings of the National Academy of Sciences of the United States of America|March 11, 2004
Transcriptional switch by activating transcription factor 2-derived peptide sensitizes melanoma cells to apoptosis and inhibits their tumorigenicityAnindita Bhoumik, Nic Jones, Ze'ev Ronai
Cancer Research|November 19, 2004
Inhibition of melanoma growth and metastasis by ATF2-derived peptidesAnindita Bhoumik, Lisa Gangi, Ze'ev Ronai
Pageof 10